Spots Global Cancer Trial Database for Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

Official Title: Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix - a Rare Tumor

Study ID: NCT05046080

Conditions

Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type

Interventions

Electronic Health Record Review

Laboratory Biomarker Analysis

Study Description

Brief Summary: This study aims to provide a comprehensive report on clinicopathologic features, immunohistochemical/biomarker testing and molecular profile of cervical clear cell carcinoma. This study may help researchers learn more about the molecular profile of cervical clear cell carcinoma.

Detailed Description: PRIMARY OBJECTIVE: I. To perform a retrospective clinicopathologic study on patients diagnosed and treated for clear cell carcinoma of the cervix at M D Anderson Cancer Center (MDACC) and to delineate the immunohistochemical and molecular profile of these cases. OUTLINE: Patients' medical records are reviewed retrospectively, and archival tumor tissue analyzed by immunohistochemistry and next generation sequencing.